Epstein-Barr virus-encoded deoxyuridine triphosphate nucleotidohydrolase (dUTPase): a potential target for drug therapy.
Kremmer
E
E
GSF-Institut für Immunologie, München, Germany.
Sommer
P
P
Grässer
F A
FA
D000818:Animals; D000911:Antibodies, Monoclonal; D000918:Antibody Specificity; D000998:Antiviral Agents; D001402:B-Lymphocytes / Q000201:enzymology; D015415:Biomarkers; D002051:Burkitt Lymphoma; D002460:Cell Line; D015195:Drug Design; D004854:Herpesvirus 4, Human / Q000201:enzymology*; D006801:Humans; D007244:Infectious Mononucleosis / Q000188:drug therapy*; D011755:Pyrophosphatases / Q000032:analysis / Q000037:antagonists & inhibitors / Q000378:metabolism*; D051381:Rats; D011919:Rats, Inbred Strains; D011994:Recombinant Proteins / Q000032:analysis; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology
D000911:Antibodies, Monoclonal; D000998:Antiviral Agents; D015415:Biomarkers; D011994:Recombinant Proteins; D011755:Pyrophosphatases; C020020:dUTP pyrophosphatase; D013755:Tetradecanoylphorbol Acetate